|
AEVIS VICTORIA SA / Key word(s): Investment Ad hoc announcement pursuant to Art. 53 LR Fribourg, 7 June 2022 AEVIS VICTORIA SA takes a stake in the Well digital health platform AEVIS VICTORIA (AEVIS) pursues the development of integrated healthcare in Switzerland and takes a stake in the Well digital health platform. Well enables patients living in Switzerland to benefit from easy digital access to a growing network of service providers. As a shareholder, AEVIS will play a key role in the further expansion of Well, together with its four founding partners: CSS, Medi24, Visana and Zur Rose Group. This collaboration seeks to network service providers in the healthcare industry and to unite Well’s digital services with the healthcare offering of Swiss Medical Network, one of the two leading private hospital groups in Switzerland, subsidiary of AEVIS. The parties have agreed not to disclose the details of the transaction. To advance integrated healthcare in Switzerland, Well is developing an open digital health platform in cooperation with health insurers, service providers and platform users. It is already possible for users to schedule appointments with Amavita, Coop Vitality or Sun Store pharmacies, check symptoms, consult physicians online, schedule medical appointments or submit health documents. In parallel, Well is also providing support to healthcare professionals, who can bring improved functionality and expanded data to their existing systems, booking appointments through Well and consulting the health data their patients make available via the app. For further information: End of ad hoc announcement |
1369189 07-Jun-2022 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
Special
